ResearchMoz

MediPoint: Diagnostic X-ray Imaging - US Analysis and Market Forecasts

GlobalData
Published Date » 2014-07-07
No. Of Pages » 157
   
 An early diagnosis of disease is the foundation for increasing survival rates. Diagnostic X-ray imaging is the most widely used technique to achieve early detection and clinical assessment of adult and pediatric patients alike, making it a cornerstone of disease control. This report provides an analysis of the diagnostic X-ray imaging market in the US, the 5EU (France, Germany, Italy, Spain, and the UK), and some of the Asia-Pacific (APAC) regions (Australia, China, India, and Japan), and identifies the unmet needs in this diagnostic X-ray systems market. This report also discusses physician attitudes towards the utilization and perception of different types of X-ray imaging techniques, and the future of diagnostic X-ray imaging in the face of rapid technological advancements and...
Table of Content

1 Table of Contents 5
1.1 List of Tables 12
1.2 List of Figures 15

2 Introduction 16
2.1 Catalyst 16
2.2 Related Reports 16

3 Industry Overview 17
3.1 Principle of Diagnostic X-ray Imaging 17
3.2 System Overview 19
3.3 Operation Overview 20
3.4 Applications of X-ray Imaging 21
3.4.1 Overview 21
3.4.2 Chest Radiography 21
3.4.3 Skeletal Defects and Pathology 23
3.4.4 Abdominal and Gastrointestinal Examinations 24
3.5 Advantages and Disadvantages of Diagnostic X-ray Imaging 24
3.5.1 Overview 24
3.5.2 SWOT Analysis 25
3.6 Market Access 26
3.6.1 Product Life Cycle 26
3.6.2 Purchasing Decisions 27
3.7 Brand Loyalty 29
3.8 Regulatory Process 30
3.9 Current Reimbursement Trends 31
3.10 Procedure Trends 32
3.10.1 Overview 32
3.10.2 US 33
3.11 Mergers and Acquisitions, Key Partnerships 34

4 Unmet Needs Analysis 35
4.1 Overview 35
4.2 Product Improvement 35
4.3 Lack of Standardization 36
4.4 Need for Cost-Containment 37

5 Market Opportunity Analysis 39
5.1 Lighter X-ray Imaging Systems on the Horizon 39

6 Market Drivers and Barriers 41
6.1 Overview 41
6.2 Driver: Rising Prevalence of Diseases and Aging Population 41
6.2.1 Sports-Related Injuries 41
6.2.2 Trauma 42
6.2.3 Smoking 42
6.2.4 Aging 42
6.3 Driver: Escalating Population 43
6.4 Driver: Increased Demand for Cost-Effective Quality Healthcare 43
6.5 Driver: Implementation of PACS/RIS to Drive Growth in Digital X-ray Imaging 44
6.6 Driver: Increased Patient Awareness Regarding Excessive Radiation Dose Associated with CT Imaging 44
6.7 Driver: Digital Tomosynthesis Unlocks New Frontiers for X-ray Imaging 45
6.8 Driver: Sustained Monitoring Applications Using Diagnostic X-ray Imaging 47
6.9 Driver: Digital Mobile Radiography Systems 48
6.10 Driver: Steady Reimbursement and Other Government Funding 49
6.11 Barrier: Growth of X-ray Examinations is Inhibited by Advanced Imaging Modalities 49
6.12 Barrier: Shortage of Radiologists 51
6.13 Barrier: Lack of Enthusiasm Surrounding X-ray Imaging, and Shrinking Radiology Training 52
6.14 Barrier: Less Monetary Incentive to Use X-ray Imaging Compared with Other Technique 53
6.15 Barrier: Lifestyle-Related Diseases Negatively Impact the Use of X-ray Imaging 54
6.16 Barrier: Reduced Hospital Budgets 54
6.17 Barrier: Refurbished Equipment Sales 55
6.18 Barrier: Medical Device Excise Tax 56
6.19 Barrier: Hospital Consolidation 56

7 Competitive Assessment 58
7.1 Overview 58
7.2 Evolution of Detector Technology 58
7.3 Analog X-ray Systems 61
7.3.1 Overview 61
7.3.2 SWOT Analysis 63
7.4 Digital X-ray Systems 63
7.4.1 Overview 63
7.4.2 CR X-ray Systems 64
7.4.3 DR X-ray Systems 65
7.5 CR Versus DR 66
7.6 Key Product Profiles 68
7.6.1 AeroDR X70 (Konica Minolta) 68
7.6.2 FCR Profect One Plus/CS Plus (Fujifilm Holdings) 70
7.6.3 ddRFormula (Swissray International) 72
7.6.4 DigitalDiagnost (Philips Healthcare) 73
7.6.5 Digix (Allengers Medical Systems) 75
7.6.6 DirectView (Carestream Health) 76
7.6.7 Discovery XR656 (GE Healthcare) 78
7.6.8 DX-D 100 (Agfa Healthcare) 79
7.6.9 Mobilett XP (Siemens Healthcare) 81
7.6.10 Proteus XR/a (GE Healthcare) 82
7.6.11 Radrex-i (Toshiba Medical Systems) 83
7.6.12 Ysio (Siemens Healthcare) 85

8 Pipeline Assessment 87
8.1 Overview 87
8.2 Appropriate Digital X-ray Imaging System (EssentialMed) 87
8.2.1 Overview 87
8.2.2 SWOT Analysis 88
8.3 MODIS X-ray System (Tribogenics) 88
8.3.1 Overview 88
8.3.2 SWOT Analysis 89
8.4 Flat-Panel Source-Based Portable X-ray Device (Radius Diagnostics) 90
8.4.1 Overview 90
8.4.2 SWOT Analysis 91
8.5 Diffraction Enhanced Medical Imaging System (NextRay) 91
8.5.1 Overview 91
8.5.2 SWOT Analysis 92
8.6 X-ray Imaging Device (Massachusetts Institute of Technology) 92
8.6.1 Overview 92
8.6.2 SWOT Analysis 93
8.7 TBView 1000 (University of Waterloo) 93
8.7.1 Overview 93
8.7.2 SWOT Analysis 94

9 Current and Future Players 95
9.1 Overview 95
9.2 Trends in Corporate Strategy 95
9.3 Who Is on Top? 97
9.4 Agfa Healthcare 97
9.4.1 Overview 97
9.4.2 Portfolio Assessment 97
9.4.3 SWOT Analysis 98
9.5 Canon 99
9.5.1 Overview 99
9.5.2 Portfolio Assessment 99
9.5.3 SWOT Analysis 100
9.6 Carestream Health 100
9.6.1 Overview 100
9.6.2 Portfolio Assessment 101
9.6.3 SWOT Analysis 101
9.7 Fujifilm Holdings 102
9.7.1 Overview 102
9.7.2 Portfolio Assessment 102
9.7.3 SWOT Analysis 103
9.8 GE Healthcare 103
9.8.1 Overview 103
9.8.2 Portfolio Assessment 104
9.8.3 SWOT Analysis 105
9.9 Hitachi Medical 105
9.9.1 Overview 105
9.9.2 Portfolio Assessment 106
9.9.3 SWOT Analysis 107
9.10 Konica Minolta 107
9.10.1 Overview 107
9.10.2 Portfolio Assessment 107
9.10.3 SWOT Analysis 108
9.11 Mindray Medical International 109
9.11.1 Overview 109
9.11.2 Portfolio Assessment 109
9.11.3 SWOT Analysis 110
9.12 Philips Healthcare 110
9.12.1 Overview 110
9.12.2 Portfolio Assessment 111
9.12.3 SWOT Analysis 112
9.13 Samsung Electronics 112
9.13.1 Overview 112
9.13.2 Portfolio Assessment 113
9.13.3 SWOT Analysis 113
9.14 Shimadzu Corporation 114
9.14.1 Overview 114
9.14.2 Portfolio Assessment 114
9.14.3 SWOT Analysis 115
9.15 Siemens Healthcare 116
9.15.1 Overview 116
9.15.2 Portfolio Assessment 116
9.15.3 SWOT Analysis 117
9.16 Swissray International 118
9.16.1 Overview 118
9.16.2 Portfolio Assessment 118
9.16.3 SWOT Analysis 119
9.17 Toshiba Medical Systems 119
9.17.1 Overview 119
9.17.2 Portfolio Assessment 119
9.17.3 SWOT Analysis 120
9.18 Other Companies 121

10 Market Outlook 122
10.1 Company Market Share 122
10.2 Market Revenue 123

11 Appendix 129
11.1 Bibliography 129
11.2 Definitions 141
11.3 Abbreviations 142
11.4 Research Methodology 146
11.4.1 Overview 146
11.4.2 Coverage 146
11.4.3 Secondary Research 146
11.5 Physicians and Specialists Included in this Study 148
11.6 Primary Research 150
11.6.1 Primary Research - Key Opinion Leader Interviews 150
11.6.2 Expert Panel Validation 150
11.6.3 Stakeholder Survey 151
11.7 Forecasting Methodology 153
11.8 About the Authors 154
11.8.1 Analysts 154
11.8.2 Global Head of Healthcare 155
11.9 About GlobalData 156
11.10 Disclaimer 156

List of Tables


Table 1: Advantages and Disadvantages of X-ray Imaging, 2014 25
Table 2: Diagnostic X-ray Imaging SWOT Analysis, 2014 25
Table 3: Average Product Life Cycle of X-ray Systems 26
Table 4: Recent Key Events in the Diagnostic X-ray Imaging Market 34
Table 5: Product Improvement Strategies 35
Table 6: Equipment Cost-Reduction Strategies 38
Table 7: Diagnostic X-ray Imaging Market - Drivers and Barriers, 2014 41
Table 8: Analog X-ray Systems 62
Table 9: Analog X-ray Systems SWOT Analysis, 2014 63
Table 10: CR X-ray Systems 64
Table 11: CR X-ray Systems SWOT Analysis, 2014 65
Table 12: DR X-ray Systems 66
Table 13: DR X-ray Systems SWOT Analysis, 2014 66
Table 14: Comparison of CR and DR X-ray Technology 68
Table 15: AeroDR X70 Product Profile, 2014 69
Table 16: AeroDR X70 SWOT Analysis, 2014 69
Table 17: FCR Profect One Plus/CS Plus Product Profile, 2014 71
Table 18: FCR Profect One Plus/CS Plus SWOT Analysis, 2014 71
Table 19: ddRFormula Product Profile, 2014 72
Table 20: ddRFormula SWOT Analysis, 2014 73
Table 21: DigitalDiagnost Product Profile, 2014 74
Table 22: DigitalDiagnost SWOT Analysis, 2014 74
Table 23: Digix Product Profile, 2014 75
Table 24: Digix SWOT Analysis, 2014 76
Table 25: DirectView Product Profile, 2014 77
Table 26: DirectView SWOT Analysis, 2014 77
Table 27: Discovery XR656 Product Profile, 2014 78
Table 28: Discovery XR656 SWOT Analysis, 2014 79
Table 29: DX-D 100 Product Profile, 2014 80
Table 30: DX-D 100 SWOT Analysis, 2014 80
Table 31: Mobilett XP Product Profile, 2014 81
Table 32: Mobilett XP SWOT Analysis, 2014 82
Table 33: Proteus XR/a Product Profile 83
Table 34: Proteus XR/a SWOT Analysis, 2013 83
Table 35: Radrex-i Product Profile 84
Table 36: Radrex-i SWOT Analysis, 2014 84
Table 37: Ysio Product Profile, 2014 85
Table 38: Ysio SWOT Analysis, 2014 86
Table 39: Appropriate Digital X-ray Imaging System SWOT Analysis, 2014 88
Table 40: MODIS X-ray System SWOT Analysis, 2014 89
Table 41: Flat-Panel Source-Based Portable X-ray Device SWOT Analysis, 2014 91
Table 42: Diffraction Enhanced Medical Imaging System SWOT Analysis, 2014 92
Table 43: X-ray Imaging Device SWOT Analysis, 2014 93
Table 44: TBView 1000 SWOT Analysis, 2014 94
Table 45: Agfa Healthcare SWOT Analysis, 2014 98
Table 46: Canon SWOT Analysis, 2014 100
Table 47: Carestream Health SWOT Analysis, 2014 101
Table 48: Fujifilm Holdings SWOT Analysis, 2014 103
Table 49: GE Healthcare SWOT Analysis, 2014 105
Table 50: Hitachi Medical SWOT Analysis, 2014 107
Table 51: Konica Minolta SWOT Analysis, 2014 108
Table 52: Mindray Medical International SWOT Analysis, 2014 110
Table 53: Philips Healthcare SWOT Analysis, 2014 112
Table 54: Samsung Electronics SWOT Analysis, 2014 113
Table 55: Shimadzu Corporation SWOT Analysis, 2014 115
Table 56: Siemens Healthcare SWOT Analysis, 2014 117
Table 57: Swissray International SWOT Analysis, 2014 119
Table 58: Toshiba Medical Systems SWOT Analysis, 2014 120
Table 59: Other Companies in the Diagnostic X-ray Imaging Market, 2014 121
Table 60: Diagnostic X-ray Imaging, Company Market Share, US, 2012 122
Table 61: US Diagnostic X-ray Systems Sales ($m), by Segment, 2011-2020 123
Table 62: Total Unit Sales of Diagnostic X-ray Systems, US, 2011-2020 125
Table 63: Change in ASP of X-ray Systems, US, 2011-2020 127
Table 64: Primary Research Summary 151
Table 65: Primary Research Participants’ Professional Affiliation 152

List of Figures


Figure 1: Electromagnetic Spectrum 17
Figure 2: X-ray Scan of the Ankle 18
Figure 3: Operation of X-ray Imaging 20
Figure 4: Evolution of Detector Technology 58
Figure 5: Types of Digital Detectors 60
Figure 6: Diagnostic X-ray Imaging, Company Market Share, US, 2012 122
Figure 7: US Overall Sales ($m), Diagnostic X-ray Systems, 2011-2020 124
Figure 8: Total Unit Sales of Diagnostic X-ray Systems, US, 2011-2020 125
Figure 9: US Sales Forecast ($m) for Diagnostic X-ray Systems, by Segment, 2013 and 2020 126
Figure 10: Change in ASP of X-ray Systems, US, 2011-2020 128
Figure 11: Primary Research Summary 151
Figure 12: Primary Research Participants’ Professional Affiliation 152

Upcoming Reports:

Poland: rape oil market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the rape oil market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the rape oil market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main...
Greece: insecticides market
By - Williams and Marshal Strategy
e insecticides market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main market participants, the price fluctuations, the growth and demand drivers of the market and the factors, influencing its development. Last but not least, the report presents a general overview of the economy of Greece in 2008-2012 and a...
Bio-Based Organic Acids Market - Global Industry Analysis, Size, Share, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Since the last decade, the demand for bio-based organic acids is growing at a steady pace owing to the impact of conventional organic acids on the environment.  In order to cater to this growing demand, more and more organic acid is being produced from renewable sources such as feedstock.  The market for organic acid synthesized from renewable raw material is also driven by the stringent regulations imposed by regulatory bodies of various nations on conventional organic acid producers. Bio-based alternatives for organic acid are eco-friendly and are frugal compared...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Private Schools Have Higher Male Teaching Staff Than State Schools: Report
Oct 22, 2014  
Private and state education has always been a matter of debate across the UK. A recent study has shown that when it comes to teaching employment options, the difference between state-run and private education in terms of gender balance is absolutely clear.  A report by the Independent Schools Council (ISC) shows that while women dominate both the education medium, the number of...
Abbots First Australian Renewable Energy Deal Rejected
Oct 22, 2014  
The Abbot government’s initial deal for a renewable energy plan has been immediately rejected by the clean energy industry and Labor. The negotiations are about a bipartisan agreement regarding the future of the Australian renewable energy target. The Labor party rejected the first plan as being a job-killer before it was even announced. The plan, they said, would protect solar...
Chemical Production in Europe Flatlines in First Seven Months of 2014
Oct 21, 2014  
The recently published report by European Chemical Industry Council (Cefic) shows overall chemical production in Europe has flatlined in first seven months of this year. Though the initial four months showed a positive trend, the production volumes dropped in July 2014 and in the following months as well. The contraction in output in the three consecutive months has nullified the upward trend...
Actavis to Compete for Omega Pharma
Oct 20, 2014  
Actavic Plc has declared that it will become one of the bidders for the Omega Pharma NV deal, as the United States based drug maker keeps searching for more takeovers. Actavis will be competing against Boehringer Ingelheim GmbH, Sanofi and Perrigi Co. for Omega Pharma. Actavis places themselves as a potential suitor along with quarry in a multitude of potential pharma combinations....
Sale of iPhone Fuels UKs s
Oct 20, 2014  
With the sale of Apple Inc.’s latest smartphone, consumer expenditure on electronics has registered a three-year high this September. The new iPhone 6 and iPhone 6 Plus were launched in the U.K. on September 19 and buyers from across the country raced to purchase the newest smartphone. Both these smartphones are so far the fastest selling Apple products with a sale of over 10 million...